Following on from the statement released by the US Food and Drug Administration (FDA) regarding vaginal rejuvenation treatments, respected publication Aesthetics Journal has published an article that might be of interest to our clients. You can read it by clicking on the link here: “FDA shares concerns over vaginal rejuvenation treatments”.
Dr. Mayoni is the key opinion leader for sexual wellness treatment Viveve, and welcomes the extra scrutiny being given to vaginal rejuvenation treatments:
“I am proud to be the head UK trainer and brand ambassador for Viveve. The warning from the FDA comes at an important time, as there are now many vaginal rejuvenation brands out there and women need to know that the treatment they choose has been properly tested for safety.”
We would like to reassure our clients that the vaginal rejuvenation treatment that we offer at The Clinic, Geneveve by Viveve, is NOT one of those companies included in the FDA’s statement or warning letters. You can read our full response in our blog post here: “Dr Mayoni Welcomes Calls for Increased Safety of Vaginal Rejuvenation Treatments”.
And if you have any concerns or questions, please feel free to call us at The Clinic at any time, on 020 8699 9496. We are always more than happy to help with information and advice.
